Pathways to neuronal injury and apoptosis in HIV-associated dementia

Nature

Volumn 410, Issue 6831, 2001, Pages 988-994

  Kaul, Marcus ^a   Garden, Gwenn A ^b   Lipton, Stuart A ^a  

^a BURNHAM INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN; FREE RADICALS; NEUROLOGY; PROTEINS; TOXICITY;

HUMAN IMMUNODEFICIENCY VIRUS (HIV-1); NEURONAL INJURY;

VIRUSES;

CHEMOKINE RECEPTOR;

APOPTOSIS; ASTROCYTE; CELLULAR IMMUNITY; DEMENTIA; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACROPHAGE; MICROGLIA; NERVE INJURY; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

AIDS DEMENTIA COMPLEX; APOPTOSIS; ASTROCYTES; BRAIN; HIV-1; HUMANS; MACROPHAGES; MICROGLIA; NEURONS; RECEPTORS, CHEMOKINE; RECEPTORS, HIV; RETROVIRIDAE PROTEINS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0035912198     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/35073667     Document Type: Review

References (96)

1. Trends in incidence of AIDS illnesses in Australia from 1983 to 1994: The Australian AIDS cohort
2. Highly active antiretroviral treatment in HIV infection: Benefits for neuropsychological function
3. Changes to AIDS dementia complex in the era of highly active antiretroviral therapy
4. HIV-associated dementia
5. Human immunodeficiency virus-associated dementia
6. Treating AIDS dementia
7. Dementia associated with the acquired immunodeficiency syndrome
8. Dementia in AIDS patients: Incidence and risk factors. Multicenter AIDS Cohort Study
9. Neurocognitive impairment is an independent risk factor for death in HIV infection
10. HIV-associated neurologic disease incidence changes
11. Antiretroviral drugs and the central nervous system
12. HIV infection and dementia
13. Evidence for independent development of resistance to HIV-1 reverse transcriptase inhibitors in the cerebrospinal fluid
14. Chemokines in the CNS: Plurifunctional mediators in diverse states
15. Microglia-passaged simian immunodeficiency virus induces neurophysiological abnormalities in monkeys
16. Cytotoxic T lymphocytes and HIV-1 related neurologic disorders
17. Monocyte adhesion to endothelium in simian immunodeficiency virus-induced AIDS encephalitis is mediated by vascular cell adhesion molecule- 1/alpha 4 beta 1 integrin interactions
18. TNF-alpha opens a paracellular route for HIV-1 invasion across the blood-brain barrier
19. Evidence of blood-brain barrier alteration and activation in HIV-1 gp 120 transgenic mice
20. Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage
21. Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome
22. Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain
23. Distribution of brain HIV load in AIDS
24. Immunocytochemical quantitation of human immunodeficiency virus in the brain: Correlations with dementia
25. Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders
26. Cellular localization of tumor necrosis factor mRNA in neurological tissue from HIV-infected patients by combined reverse transcriptase/polymerase chain reaction in situ hybridization and immunohistochemistry
27. Study of receptor-mediated neurotoxins released by HIV-1-infected mononuclear phagocytes found in human brain
28. Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: Relationship to clinical and neurological status
29. Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder
30. Neurodegeneration of somatostatin-immunoreactive neurons in HIV encephalitis
31. Selective neuronal vulnerability in HIV encephalitis
32. Neuronal apoptosis in HIV infection in adults
33. Apoptotic neurons in brains from paediatric patients with HIV-1 encephalitis and progressive encephalopathy
34. Evidence of apoptotic cell death in HIV encephalitis
35. Neuronal apoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damage
36. Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1
37. The envelope glycoprotein of human immunodeficiency virus type 1 stimulates release of neurotoxins from monocytes
38. Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity
39. Quinolinic acid production is related to macrophage tropic isolates of HIV-1
40. Cytokine-stimulated, but not HIV-infected, human monocyte-derived macrophages produce neurotoxic levels of L-cysteine
41. Apoptosis and necrosis: Two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures
42. Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity
43. Uptake of HIV-1 Tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands
44. CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia
45. HIV-1 entry inhibitors: Evading the issue
46. Cellular localization of the chemokine receptor CCR5. Correlation to cellular targets of HIV-1 infection
47. Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis
48. Intracellular CXCR4 signaling, neuronal apoptosis and neuropathogenic mechanisms of HIV-1-associated dementia
49. Chemokines and receptors in HIV encephalitis
50. Chemokine and chemokine-receptor expression in human glial elements: Induction by the HIV protein, Tat, and chemokine autoregulation
51. In vivo distribution of the human immunodeficiency virus/simian immunodeficiency virus coreceptors: CXCR4, CCR3, and CCR5
52. SDF-1α-mediated modulation of synaptic transmission in rat cerebellum
53. Differential signalling of the chemokine receptor CXCR4 by stromal cell-derived factor 1 and the HIV glycoprotein in rat neurons and astrocytes
54. Apoptosis induced by infection of primary brain cultures with diverse human immunodeficiency virus type 1 isolates: Evidence for a role of the envelope
55. Neuronal apoptosis induced by HIV-1 gp 120 and the chemokine SDF-1α is mediated by the chemokine receptor CXCR4
56. Cerebrospinal fluid beta chemokine concentrations in neurocognitively impaired individuals infected with human immunodeficiency virus type 1
57. Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication
58. Beta-chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia
59. Identification of CX3CR1. A chemotactic receptor for the human CX3C chemokine fractalkine and a fusion coreceptor for HIV-1
60. Neuronal fractalkine expression in HIV-1 encephalitis: Roles for macrophage recruitment and neuroprotection in the central nervous system
61. Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival
62. Characterization of fractalkine in rat brain cells: Migratory and activation signals for CX3CR-1-expressing microglia
63. Fractalkine cleavage from neuronal membranes represents an acute event in the inflammatory response to excitotoxic brain damage
64. Isolation and long-term culture of primary ocular human immunodeficiency virus type 1 isolates in primary astrocytes
65. HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists
66. Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-α gene expression in endotoxin-stimulated primary glial cultures
67. Central nervous system damage produced by expression of the HIV-1 coat protein gp 120 in transgenic mice
68. Dysregulation of signal transduction pathways as a potential mechanism of nervous system alterations in HIV-1 gp 120 transgenic mice and humans with HIV-1 encephalitis
69. Tumor necrosis factor α inhibits glutamate uptake by primary human astrocytes. Implications for pathogenesis of HIV-1 dementia
70. Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: Implications for the neuropathogenesis of HIV disease
71. Prostaglandins stimulate calcium-dependent glutamate release in astrocytes
72. Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia
73. Immunologic NO synthase: Elevation in severe AIDS dementia and induction by HIV-1 gp41
74. CD4-independent association between HIV-1 gp 120 and CXCR4: Functional chemokine receptors are expressed in human neurons
75. gp 120 can revert antagonism at the glycine site of NMDA receptors mediating GABA release from cultured hippocampal neurons
76. Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp 120: Protection by memantine
77. Extracellular HIV-1 virus protein R causes a large inward current and cell death in cultured hippocampal neurons: Implications for AIDS pathology
78. Apoptosis induced by HIV-1 infection of the central nervous system
79. HIV-1 infected mononuclear phagocyte secretory products affect neuronal physiology leading to cellular demise: Relevance for HIV-1-associated dementia
80. Human immunodeficiency virus-infected macrophages produce soluble factors that cause histological and neurochemical alterations in cultured human brains
81. Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide
82. Prospects for clinically tolerated NMDA antagonists: Open-channel blockers and alternative redox states of nitric oxide
83. An experimental model system for HIV-1-induced brain injury
84. Prevention of HIV-1 gp 120-induced neuronal damage in the central nervous system of transgenic mice by the NMDA receptor antagonist memantine
85. Mitochondrial and extramitochondrial apoptotic signaling pathways in cerebrocortical neurons
86. Role of caspases in N-methyl-D-aspartate-induced apoptosis in cerebrocortical neurons
87. p38 MAP kinase mediates bax translocation in nitric oxide-induced apoptosis in neurons
88. HIV-gp 120 induces apoptosis in cultured cortical neurons by pathways involving caspases 8 and 9 and TNF-α
89. Differential modulation of cell death proteins in human brain cells by tumor necrosis factor alpha and platelet activating factor
90. Neuronal apoptosis induced by HIV-1 Tat protein and TNF-α: Potentiation of neurotoxicity mediated by oxidative stress and implications for HIV-1 dementia
91. Memantine prevents HIV coat protein-induced neuronal injury in vitro
92. Randomized trial of the platelet-activating factor antagonist lexipafant in HIV-associated cognitive impairment. Neurological AIDS Research Consortium
93. A phase I/II trial of nimodipine for HIV-related neurologic complications
94. Transdermal selegiline in HIV-associated cognitive impairment: Pilot, placebo-controlled study
95. Neuroprotective activity of chemokines against N-methyl-D-aspartate or β-amyloid-induced toxicity in culture
96. Apoptosis in the nervous system